Studies in tumour cells have shown that HIF-1α can mediate LOX expression by binding to HREs in the LOX promoter so that intensive ECM remodelling can occur to meet the demand for tumour cell invasion and metastasis (Wang et al., 2017). The gene discussed is HIF1A; the disease is neoplasm.